Actelion - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Actelion M&A Summary

Actelion has acquired 2 companies of its own.

Actelion’s largest acquisition to date was in 2006, when it acquired CoTherix for $420M. Actelion has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Actelion Ownership

Who owns Actelion?

Actelion is owned by Johnson & Johnson. It was acquired on January 26, 2017.

Actelion Business Overview

Where is Actelion headquartered?

Actelion is headquartered in Allschwil, Switzerland.

How many employees does Actelion have?

Actelion has 2,500 employees.

What sector is Actelion in?

Actelion is a life science company.

When was Actelion founded?

Actelion was founded in 1997.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 1

Actelion Ltd.

Gewerbestrasse 16,
Allschwil, 04123
Switzerland,
+41-61-5656565
www.actelion.com

Actelion Ltd. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical need. Actelion is a leader in the field of pulmonary arterial hypertension (PAH). The Company's portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications. Although not available in all countries, Actelion has treatments approved by health authorities for a number of specialist diseases including Type 1 Gaucher disease, Niemann-Pick type C disease, Digital Ulcers in patients suffering from systemic sclerosis, and mycosis fungoides type cutaneous T-cell lymphoma. Actelion was formed in 1997 and has its corporate headquarters in Allschwil, Switzerland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
vol $670M $670M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Ceptaris Therapeutics, Inc. 2013-07-31 250M USD Add-on Acquisition
Malvern, Pennsylvania
CoTherix, Inc. 2006-11-20 420M USD Add-on Acquisition
South San Francisco, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (100%) 670M (100%) - -
Total 2 $670M - -

By Geo

State/Country Buy Value Sell Value
United States 2 670M - -
  Pennsylvania 1 250M - -
  California 1 420M - -
Total 2 $670M - -

Top M&A Advisors

Financial Deals
Moelis & Co.
1

Deal Values

buy # Total
$100M to $1B 2 $670M
TOTAL $670M
Largest CoTherix, Inc.
$420M (2006-11-20)

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Actelion

Life Science Companies , Switzerland Companies